Compile Data Set for Download or QSAR
Report error Found 162 Enz. Inhib. hit(s) with all data for entry = 50016551
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170537(6-Phenoxymethyl-pyridine-2-carboxylic acid (3-hydr...)
Affinity DataIC50: 13nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170540(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 17nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170480(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 26nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170475(6-Phenoxymethyl-pyridine-2-carboxylic acid (6-hydr...)
Affinity DataIC50: 40nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170473(6-Phenoxymethyl-pyridine-2-carboxylic acid (4-hydr...)
Affinity DataIC50: 40nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170491(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 43nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170500(10-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-...)
Affinity DataIC50: 74nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170491(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 74nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170480(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 87nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170482(9-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-p...)
Affinity DataIC50: 96nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170526(2-[3-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-be...)
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170487(Quinoline-2-carboxylic acid (4-hydroxycarbamoylmet...)
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170502(6-Phenoxymethyl-pyridine-2-carboxylic acid (4-hydr...)
Affinity DataIC50: 190nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170492(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 200nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170514(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 230nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170492(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170547(({[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-py...)
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170529(3-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-p...)
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170550(4-(4-Chloro-phenoxy)-N-(4-hydroxycarbamoylmethyl-t...)
Affinity DataIC50: 320nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170561(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 350nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170554(1-Phenyl-1,4-dihydro-quinoline-4-carboxylic acid (...)
Affinity DataIC50: 380nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170501(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 390nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170511(N-(4-Hydroxycarbamoylmethyl-thiazol-2-yl)-3-triflu...)
Affinity DataIC50: 430nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170515((S)-2-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethy...)
Affinity DataIC50: 460nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170501(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 500nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170479(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 520nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170531(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 620nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170539(9-[3-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-be...)
Affinity DataIC50: 630nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170466(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 630nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170558(2-[3-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-be...)
Affinity DataIC50: 650nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170479(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 670nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170512(2-[3-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-be...)
Affinity DataIC50: 680nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170564(6-Phenoxymethyl-pyridine-2-carboxylic acid (5-hydr...)
Affinity DataIC50: 770nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170554(1-Phenyl-1,4-dihydro-quinoline-4-carboxylic acid (...)
Affinity DataIC50: 790nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170465(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 830nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170466(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 890nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170502(6-Phenoxymethyl-pyridine-2-carboxylic acid (4-hydr...)
Affinity DataIC50: 920nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170524([3-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-benz...)
Affinity DataIC50: 920nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170552(Naphthalene-1-carboxylic acid (4-hydroxycarbamoylm...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170509((R)-2-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethy...)
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170540(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170552(Naphthalene-1-carboxylic acid (4-hydroxycarbamoylm...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170528(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170535(2-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-p...)
Affinity DataIC50: 1.24E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170517(2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indo...)
Affinity DataIC50: 1.28E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170480(6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-pyrid...)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50170465(6-Phenoxymethyl-pyridine-2-carboxylic acid [4-(1-h...)
Affinity DataIC50: 1.36E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170523(3-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-p...)
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170522(N-{6-[(hydroxyamino)carbonyl]pyridin-2-yl}-6-(phen...)
Affinity DataIC50: 1.47E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50170506(9-{[6-(4-Acetyl-2-ethyl-5-hydroxy-phenoxymethyl)-p...)
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: